Tag: GPX
New liquid embolic multicentre trial successfully enrols final patient
Fluidx Medical announces completion of trial enrolment for its GPX embolic device. In this multicentre trial, GPX was used to treat a variety of...
New embolic device demonstrates superior vessel filling in tumour models
Fluidx Medical disclosed study results examining extent of vessel filling using the GPX embolic device compared to microspheres, a common treatment for many types...
Fluidx Medical’s embolic device demonstrates promising visibility
Fluidx Medical Technology has announced the results of the GPX-Clear embolic device in-vivo research which uses the base GPX technology and incorporates an intermediate-term...
Fluidx Medical Technology announces Series A led by multinational strategic investor
Fluidx Medical Technology, has recently announced the oversubscribed closing of the first tranche of the Series A financing round. The Series A was led...
First use of new embolic device for highly targeted tumour treatment...
A novel embolization device in the interventional oncology space—the GPX embolic device (Fluidx Medical Technology)—has successfully been used in a patient to therapeutically devascularise...
New proprietary gel-coated biocompatible embolic, GPX, presented at LINC
Two scientific abstracts of a new vascular embolic device, GPX (Fluidx Medical Technology) were presented this week at the 2018 Leipzig Interventional Congress (LINC;...
